US Stock MarketDetailed Quotes

IPHYF INNATE PHARMA

Watchlist

2.245
0.0000.00%

15min DelayClose Sep 25 16:00 ET

181.73MMarket Cap-4934P/E (TTM)

INNATE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Total revenue

4.68%51.9M

309.41%49.58M

-78.43%12.11M

-18.15%56.16M

68.61M

Operating revenue

3.37%51.89M

314.51%50.2M

-78.59%12.11M

-17.18%56.57M

--68.31M

Cost of revenue

Gross profit

Operating expense

-2.17%64.57M

10.12%66.01M

8.83%59.94M

-17.84%55.08M

67.04M

Selling and administrative expenses

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

--14.78M

-General and administrative expense

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

--14.78M

Research and development costs

8.44%56.02M

9.91%51.66M

-5.44%47M

-20.97%49.71M

--62.9M

Other operating expenses

-2,342.75%-3.2M

95.72%-131K

58.24%-3.06M

31.21%-7.32M

---10.65M

Operating profit

22.87%-12.67M

65.66%-16.43M

-4,532.53%-47.83M

-31.40%1.08M

1.57M

Net non-operating interest income expense

883.33%2.54M

1,620.00%258K

-93.27%15K

-84.44%223K

1.43M

Non-operating interest income

481.87%3.18M

66.97%546K

-42.02%327K

-65.19%564K

--1.62M

Non-operating interest expense

122.22%640K

-7.69%288K

-8.50%312K

67.16%341K

--204K

Total other finance cost

----

---17K

Other net income (expense)

106.13%2.56M

-1,894.21%-41.81M

209.34%2.33M

-143.86%-2.13M

4.86M

Gain on sale of security

418.26%2.56M

-134.55%-805K

209.34%2.33M

-143.86%-2.13M

--4.86M

Special income (charges)

--0

---41M

--0

----

-Less:Impairment of capital assets

--0

--41M

--0

----

Income before tax

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

7.87M

Income tax

Net income

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-20.76M

Net income continuous Operations

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

--7.87M

Net income discontinuous operations

--0

98.21%-131K

88.39%-7.33M

-120.61%-63.16M

---28.63M

Minority interest income

Net income attributable to the parent company

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-20.76M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-20.76M

Basic earnings per share

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-0.31

Diluted earnings per share

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-0.31

Dividend per share

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Total revenue	4.68%51.9M	309.41%49.58M	-78.43%12.11M	-18.15%56.16M	68.61M
Operating revenue	3.37%51.89M	314.51%50.2M	-78.59%12.11M	-17.18%56.57M	--68.31M
Cost of revenue
Gross profit
Operating expense	-2.17%64.57M	10.12%66.01M	8.83%59.94M	-17.84%55.08M	67.04M
Selling and administrative expenses	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	--14.78M
-General and administrative expense	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	--14.78M
Research and development costs	8.44%56.02M	9.91%51.66M	-5.44%47M	-20.97%49.71M	--62.9M
Other operating expenses	-2,342.75%-3.2M	95.72%-131K	58.24%-3.06M	31.21%-7.32M	---10.65M
Operating profit	22.87%-12.67M	65.66%-16.43M	-4,532.53%-47.83M	-31.40%1.08M	1.57M
Net non-operating interest income expense	883.33%2.54M	1,620.00%258K	-93.27%15K	-84.44%223K	1.43M
Non-operating interest income	481.87%3.18M	66.97%546K	-42.02%327K	-65.19%564K	--1.62M
Non-operating interest expense	122.22%640K	-7.69%288K	-8.50%312K	67.16%341K	--204K
Total other finance cost	----	----	----	----	---17K
Other net income (expense)	106.13%2.56M	-1,894.21%-41.81M	209.34%2.33M	-143.86%-2.13M	4.86M
Gain on sale of security	418.26%2.56M	-134.55%-805K	209.34%2.33M	-143.86%-2.13M	--4.86M
Special income (charges)	--0	---41M	--0	--0	----
-Less:Impairment of capital assets	--0	--41M	--0	--0	----
Income before tax	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	7.87M
Income tax	0	0	0	0	0
Net income	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-20.76M
Net income continuous Operations	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	--7.87M
Net income discontinuous operations	--0	98.21%-131K	88.39%-7.33M	-120.61%-63.16M	---28.63M
Minority interest income
Net income attributable to the parent company	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-20.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-20.76M
Basic earnings per share	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-0.31
Diluted earnings per share	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-0.31
Dividend per share
Currency Unit	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data